UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-20859 GERON CORPORATION (Exact name of registrant as specified in its charter) (State or other jurisdiction of (I.R.S. Employer ...

() geron 1Q 2022 EARNINGS CALL May 9, 2022 Welcome and Introduction Dr. John Scarlett Chairman and Chief Executive Officer Olivia Bloom EVP, Chief Financial Officer Dr. Aleksandra Rizo EVP, Chief Medical Officer Anil Kapur EVP, Corp. Strategy and Chief Commercial Officer 2 Forward-Looking Statements Except for the historical information contained herein, this press release contains forward-looking statements made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 199 ...

Geron Corporation. (NASDAQ:GERN) Q1 2022 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Aron Feingold - VP of Investor Relations and Corporate Communications Olivia Bloom - Executive VP of Finance and Chief Financial Officer and Treasurer John Scarlett - Chairman and Chief Executive Officer Aleksandra Rizo - Executive Vice President and Chief Medical Officer Anil Kapur - Executive Vice President-Corporate Strategy and Chief Commercial Officer Conference Call Participants Gil Blum - Nee ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-20859 GERON CORPORATION (Exact name of registrant as specified in its charter) DELAWARE 75-2287752 (State or other jurisdictio ...

geron 4Q AND YE 2021 EARNINGS CALL March 10, 2022 Welcome and Introduction Dr. John Scarlett Chairman and Chief Executive Officer Olivia Bloom EVP, Chief Financial Officer Dr. Aleksandra Rizo EVP, Chief Medical Officer Anil Kapur EVP, Corp. Strategy and Chief Commercial Officer 2 Forward-Looking Statements Except for the historical information contained herein, this press release contains forward-looking statements made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act ...

Geron Corporation (NASDAQ:GERN) Q4 2021 Earnings Conference Call March 10, 2022 4:30 PM ET Company Participants Olivia Bloom – Chief Financial Officer John Scarlett – Chairman and Chief Executive Officer Aleksandra Rizo – Executive Vice President and Chief Medical Officer Anil Kapur – Executive Vice President-Corporate Strategy and Chief Commercial Officer Conference Call Participants Gil Blum – Needham & Company Joel Beatty – Baird Operator Ladies and gentlemen, thank you for standing by, and welcome to th ...

For the Fiscal Year Ended December 31, 2021 Form 10‑K Parts UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-20859 GERON CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 75-2287752 (I.R.S. Employer Identification No.) 91 ...

() geron CORPORATE PRESENTATION January 2022 Forward-Looking Statements Except for the historical information contained herein, this presentation contains forward-looking statements made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such statements, include, without limitation, those regarding: (i) that for IMerge Phase 3, Geron Corporation ("Geron" or "the Company") expects top-line results to be available in early January 202 ...

1 Second Quarter 2021 Conference Call August 16, 2021 On Today's Call | --- | --- | |--------------------------------------------------|-----------------------------------------------------------------| | Agenda Topic | Speakers | | Welcome | Olivia Bloom, EVP and Chief Financial Officer | | Introductory Remarks | John A. Scarlett, M.D., Chairman and Chief Executive Officer | | Second Quarter 2021 Financials | Olivia Bloom, EVP and Chief Financial Officer | | Phase 3 Clinical Trials Updates | Aleksandra Riz ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-20859 GERON CORPORATION (Exact name of registrant as specified in its charter) DELAWARE 75-2287752 (State or other jurisdi ...